AMA Urges FDA To Share Drug Trial Safety Data; PhRMA, BIO Rebuff Idea

The American Medical Association weighed in on the topic of clinical trial data sharing by recently adopting a resolution urging FDA to come up with ways for investigators to access safety data from industry-sponsored trials, an effort the drug and biologics industry say is unnecessary given data-sharing principles that have been developed and adopted by industry. But a consumer advocate said the AMA resolution moves in the right direction by keeping FDA the gatekeeper of such data. AMA's resolution urges...